Machine Learning

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

New data shows an AI-driven approach is enrolling IBD patients 3.4x faster, promising to accelerate the delivery of novel therapies to those in need.

With a new $50M facility from CIBC, Montreal-based AlayaCare is poised to accelerate its M&A strategy and advance its mission to digitize home care.

Appian flips from a major loss to GAAP profitability in 2025, driven by strong cloud revenue, key AI contracts, and a positive outlook for 2026.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

Phemex is betting its future on becoming a fully AI-native platform. Is this a marketing ploy or the beginning of a new standard for all crypto exchanges?

Emirates Health Services launches 'Amal,' the UAE's first AI physician assistant, aiming to enhance patient care and streamline clinical workflows.

An international team, backed by a $2M grant from a global consortium and Microsoft, will use AI to personalize care for a long-overlooked disease.

A new blood test can predict when Alzheimer's symptoms will start, years in advance. This breakthrough could revolutionize research, but raises deep ethical questions.

With a new CEO known for international scaling, Oracle consultancy Broadpin signals an aggressive push for global market leadership and integration.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

Dutch firm Besi reports booming orders for its advanced packaging tech, positioning it as a key enabler of the global AI infrastructure build-out.

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

A new report reveals a shocking spike in evasive malware, with 96% hidden in encrypted traffic, forcing a radical security rethink for businesses.

As VerticalScope preps its 2025 results, investors watch if its pivot to AI and e-commerce can overcome ad market and search engine challenges.

With 64% Q4 growth, Cafrino Gaming is proving its poker tech is a game-changer for online casinos, boosting partner revenue by over 130%.

The AI analytics firm posted strong 2025 results, unveiled new AI agents, and boosted its buyback program, signaling confidence in its enterprise strategy.

Aurora executives face Wall Street at key March conferences to justify high cash burn with a clear path to commercializing their driverless truck tech.